BBS Approved treatments

Imcivree

Imcivree (setmelanotide) is a therapy approved to reduce excess body weight and maintain long-term weight reduction in children and adults with BBS. Administered through under-the-skin injections once a day, it is designed to reduce hunger by restoring activity in the MC4R signalling pathway, which controls appetite and energy use.

Learn more